Recent advances in chemistry biology and detection technology have been found to be instrumental in identifying inhibitors of protein binding.35 As we have uncovered evidence that the interaction between KCTD12 and CDK1 play an important role in cancer progression, our next step is to screen these protein binding inhibitors to determine their usefulness in cancer therapy. The gene discussed is CDK1; the disease is cancer.